Cargando…
A Tumor-pH-Responsive Supramolecular Photosensitizer for Activatable Photodynamic Therapy with Minimal In Vivo Skin Phototoxicity
A major challenge in photodynamic therapy (PDT) is the development of new tumor-targeting photosensitizers. The tumor-specific activation is considered to be an effective strategy for designing these photosensitizers. Herein, we describe a novel tumor-pH-responsive supramolecular photosensitizer, LD...
Autores principales: | Li, Xingshu, Zheng, Bi-Yuan, Ke, Mei-Rong, Zhang, Yongfan, Huang, Jian-Dong, Yoon, Juyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558566/ https://www.ncbi.nlm.nih.gov/pubmed/28819460 http://dx.doi.org/10.7150/thno.18861 |
Ejemplares similares
-
Supramolecular agents for combination of photodynamic therapy and other treatments
por: Kwon, Nahyun, et al.
Publicado: (2021) -
Breaking the barrier: an osmium photosensitizer with unprecedented hypoxic phototoxicity for real world photodynamic therapy
por: Roque, John A., et al.
Publicado: (2020) -
Photosensitizer-Conjugated Gold Nanorods for Enzyme-Activatable Fluorescence Imaging and Photodynamic Therapy
por: Jang, Boseung, et al.
Publicado: (2012) -
ROS-Responsive Activatable Photosensitizing Agent for Imaging and Photodynamic Therapy of Activated Macrophages
por: Kim, Hyunjin, et al.
Publicado: (2013) -
Photosensitization With Supramolecular Arrays for Enhanced Antimicrobial Photodynamic Treatments
por: Vera, Cecilia, et al.
Publicado: (2021)